Top Markets
#1 Cortex Cortex +32.82%
#2 龙虾 (Lobster) 龙虾 (Lobster) +32.56%
#3 Akedo Akedo +23.89%
#4 DexNet DexNet +23.19%
#5 Pons Pons +16.16%
#6 wojak wojak +15.73%
#7 OpenEden OpenEden +15.27%
#8 APEX APEX +13.92%
#9 The Black Bull The Black Bull +10.83%
#10 Official Trump Official Trump +9.80%
Coin of the day
Cortex Cortex
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

300357
Rang in aandelen #7056
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. operates as a biopharmaceutical... Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. operates as a biopharmaceutical enterprise, primarily engaged in the discovery, development, production, and sale of medicinal products. The company's core focus is on pharmaceuticals designed for the diagnosis and management of allergic conditions, which it supplies to both the Chinese domestic market and international clientele. Additionally, its portfolio encompasses various skincare lines and stem cell-related solutions. The firm's main offices are located in Huzhou, China.
Aandeelprijs
$3.33
Marktkapitalisatie
$1.74B
Verandering (1 dag)
-1.71%
Verandering (1 jaar)
-20.92%
Land
CN
Handel Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357)

Categorie

Healthcare
Dividendrendementgeschiedenis voor Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357)
Het dividendrendement (TTM) van Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (aandelsymbool: 300357) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten
Bedrijf Dividendrendement Land
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
0.57%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
2.01%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
2.74%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
2.69%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
2.47%
US